Department of Surgery, Atrium Health Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.
Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Am J Transplant. 2022 Jun;22(6):1523-1526. doi: 10.1111/ajt.17003. Epub 2022 Mar 2.
Pancreas transplantation has an identity crisis and is at a crossroads. Although outcomes continue to improve in each successive era, the number of pancreas transplants performed annually in the United States has been static for several years in spite of increasing numbers of deceased donors. For most practitioners who manage diabetes, pancreas transplantation is considered an extreme measure to control diabetes. With expanded recipient selection (primarily simultaneous pancreas-kidney transplantation) in patients who are older, have a higher BMI, are minorities, or who have a type 2 diabetes phenotype, the controversy regarding type of diabetes detracts from the success of intervention. The absence of a clear and precise definition of pancreas graft failure, particularly one that lacks a measure of glycemic control, inhibits wider application of pancreas transplantation with respect to reporting long-term outcomes, comparing this treatment to alternative therapies, developing listing and allocation policy, and having a better understanding of the patient perspective. It has been suggested that the definition of pancreas graft failure should differ depending on the type of pretransplant diabetes. In this commentary, we discuss current challenges regarding the development of a uniform definition of pancreas graft failure and propose a potential solution to this vexing problem.
胰腺移植正面临身份危机和十字路口。尽管在每个连续的时代,移植结果都在持续改善,但尽管死亡供体数量不断增加,美国每年进行的胰腺移植数量却多年来一直保持不变。对于大多数管理糖尿病的医生来说,胰腺移植被认为是控制糖尿病的极端措施。随着受者选择范围的扩大(主要是同时进行胰腺-肾移植),包括年龄较大、BMI 较高、少数民族或具有 2 型糖尿病表型的患者,关于糖尿病类型的争议削弱了干预措施的成功。缺乏对胰腺移植物衰竭的明确和精确定义,特别是缺乏血糖控制衡量标准,这抑制了胰腺移植在报告长期结果、将这种治疗方法与替代疗法进行比较、制定列表和分配政策以及更好地了解患者观点方面的广泛应用。有人建议,胰腺移植物衰竭的定义应根据移植前糖尿病的类型而有所不同。在这篇评论中,我们讨论了目前在制定统一的胰腺移植物衰竭定义方面面临的挑战,并提出了一个潜在的解决方案。